Background: Fatigue in skeletal muscle is defined as a reduction in the physical power needed to execute a function or as an inability to maintain mitochondrial ATP production. The mitochondrial potassium channel (mitoK ATP ) participates in combating fatigue in skeletal muscle. In this work, we evaluated the role of the mitoK ATP channel activator (diazoxide) and inhibitors of the signaling routes (protein kinase C, staurosporine; protein kinase G, KT5823; and nitric oxide synthase, metil N G -Nitro-L-arginine ester, L-NAME), on muscle fatigue tension. In addition, we evaluated the main signaling routes used by the nitric oxide synthase protein and protein kinase C and G, in the presence of their specific activators. Methods: We used the anterior latissimus dorsi skeletal muscle of 2-3-week-old chicks. This muscle consists of slow muscle fibers. Tension was achieved by applying repetitive electrical stimulation that induced fatigue in an in vitro model. Results: Diazoxide significantly reduced muscle fatigue (P = 0.0002 in peak tension, P = 0.000002 in maximum tension) by increasing post-fatigue tension, in spite of the fact that 5-hydroxydecanoate, a selective inhibitor of mitoK ATP , did not suppress post-fatigue tension. Conclusion: Our results suggest a lack of direct interaction in inhibition of the signaling routes during fatigue-induced mitoK ATP activation. This effect is possibly due to the type of skeletal muscle fibers (slow), the stimulation protocols (twitch), and the animal (avian) model used in the study.
Introduction
ATP-dependent potassium channels (K ATP ) were described in patches or membrane derived from guinea pig ventricular myocytes. 1 These channels have been reported in several tissues, including β-pancreatic cells, 2 skeletal muscle fibers of amphibians, 3 mammals, [4] [5] [6] and birds, 7, 8 and in the liver-derived internal membrane mitochondria of the rat. 9 K ATP channels connect cell excitability with its metabolism and play an important role in several cellular functions by detecting the intracellular ATP/ADP relationship. 10 Mitochondrial K ATP (mitoK ATP ) has been isolated and partially purified, and its function in mitochondrial swelling has been demonstrated. 9, 11 It is composed of a sulfonylurea receptor, coupled with an inward-rectifying potassium channel (Kir 6.x), and configured in a stoichiometry of 4:4. 12 The skeletal muscle K ATP channel phenotype varies in its molecular composition, biophysical properties, and pharmacological response depending on the type of muscle. 5, 6 Garlid et al 13 demonstrated that mitoK ATP activation by diazoxide, a specific activator, was greater than sarcolemmal K ATP activation.
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Materials and methods
Ethical approval
Chickens were used in accordance with the Institute for Laboratory Animal Research 23 Guide for the Care and Use of Laboratory Animals and the Ethics Committee of the Centro Universitario de Investigaciones Biomedicas of the Universidad de Colima, which approved the protocol. To minimize animal pain and distress and to perform muscle extraction, the chicks were anesthetized beforehand with chloroform, followed by cervical dislocation and decapitation, ensuring a fast and complete separation of the head from the body, according to the American Veterinary Medical Association guidelines on euthanasia. 24 
Dissection
The anterior latissimus dorsi muscle was used for this investigation because it is exclusively composed of slow muscle fibers. The muscles were carefully dissected out, together with a piece of the humerus bone and a portion of the proximal tendon, from 2-3-week-old chicks. The spinal cord was pinned to the bottom of the experimental chamber and 3.0 surgical silk threads were tied around the humerus bone to attach the distal end of the muscle bundle (1-2 mm thick) to a force transducer (Grass FT03, West Warwick, RI) by means of a lightweight wire. To record the force, a mechanical transducer was wired to an amplifier (Cyberamp 320; Axon Instruments, Foster City, CA), and connected to an analogto-digital converter (Digidata 1322A; Axon Instruments) with a 5 Hz sampling rate. Data were acquired using the Axoscope subroutine (pClamp 9.2; Axon Instruments) on a desktop computer.
Fatigue protocols
We used different electrical stimulation frequencies to produce twitches to establish a fatigue protocol in the slow latissimus dorsi muscle, as previously described. 25 In short, supramaximal twitches at 300 ms and 0.2 Hz (Grass S-48 stimulator and SIU-5B stimuli isolation unit) were applied until bundle contractions reduced the control contraction by approximately 50% (at about 60 minutes). Pulses were delivered across platinum wire electrodes situated on both sides of the muscle. Each protocol consisted of an initial stimulation period to induce fatigue (about 50% of initial tension), after which drugs were applied to the bath for 6 minutes to maintaining stimulation. Drug withdrawal was then carried out by passing normal Ginsborg saline 26 through the muscle and continuing electrical stimulation for 15 minutes to record post-fatigue tension.
Solutions
The muscles were immersed in normal Ginsborg saline 26, 27 composed (in mM) of: 167 NaCl, 5 KCl, 2 MgCl 2 , 5 CaCl 2 , and 2 imidazole-chloride, with pH adjusted to 7.4. Finally, normal saline containing dextrose 2 g/L was added. The solutions contained a specific inhibitor of the mitoK ATP channel (5-hydroxydecanoate, 500 µM; Sigma, St Louis, MO), the mitoK ATP channel activator, diazoxide (10, 30, and 100 µM; Sigma), a potent selective inhibitor of the cGMP-dependent protein kinase (KT5823, 1 µM; Sigma), a nitric synthase oxide protein inhibitor (Nω-Nitro-L-arginine methyl ester hydrochloride, L-NAME, 100 µM; Tocris, Bristol, UK), and a protein kinase C inhibitor (staurosporine, 1 µM; Calbiochem, La Jolla, CA). All probe solutions were prepared by adding the correct volume of a stock solution dissolved in water or in dimethylsulfoxide (0.1% v/v for diazoxide and staurosporine) to the saline bath. Solution exchange was carried out via a three-way tap located at one end of the central channel of the experimental chamber.
Statistical analysis
Analysis of the experimental data took into consideration the following twitch parameters: amplitude to twitch peak tension expressed in g (from the basal resting tension to the maximal tension), and total tension (area under the tension-time curve). The control twitch was used as 100% and the probe twitch was expressed as the percentage in relation to the control. Twitch was obtained by electrical stimulation (see above).
Tension was measured as the maximum tension from the basal line to the peak before, during, and after the addition of the experimental drug (peak tension), and the tension-time integral was obtained from the area under the twitch profile. We compared each experimental condition. Data analyses were carried out using the Clampfit subroutine of the pClamp 9.2 software (Axon Instruments) and graphs were elaborated using Sigmaplot 10.0 software (Systat Software Inc. Erkrath, Germany). Results were expressed as the mean ± standard error of the mean, followed by the n value. Comparison of means was done using the Student's t-test, accepting a significant effect when P was ,0.05.
Results
Diazoxide increases twitch tension of fatigued slow skeletal muscle fibers
To determine the possible participation of mitoK ATP during post-fatigue tension in the slow skeletal muscle of the chicken, the effect of diazoxide (10, 30 , and 100 µM), considered to be a selective activator of the mitoK ATP channel, was explored ( Figure 1 ). Diazoxide at 30 µM strongly increased the tension of the fatigued muscle. Figure 2 shows that basal tension (considered as 100%) was reduced to 33.71% ± 8.62% in peak tension during fatigue; nevertheless, in the presence of diazoxide 30 µM, tension was increased to 103.38% ± 7.97% indicating postfatigue (peak tension). Figure 2B also shows the effect of diazoxide on total tension, which increased the post-fatigue tension to 163.82% ± 11.42% in relation to fatigued muscle tension (n = 4; P , 0.05). These results are consistent with previous reports in which diazoxide antagonizes fatigue. Notes: Diazoxide produced a significant increase in the total and maximal tension of twitches in fatigued muscle fibers (n = 4). *P , 0.05. Effect of 5-hydroxydecanoate on twitch tension in fatigued slow skeletal muscle fibers
To determine the possible participation of mitoK ATP in post-fatigue tension, the action of the mitoK ATP channelselective inhibitor, 5-hydroxydecanoate, was studied at the previously reported concentration range (500 µM). 22, 28 The maximum tension obtained prior to adding the drug was the control tension (100%). A 50% reduction in control tension was considered to be fatigue. The 5-hydroxydecanoate was added once fatigue was reached, and tension was recovered at 11.91% ± 1.6% in relation to muscle fatigue tension. We observed a tension recovery (15.3% ± 4.8%) in the presence of 5-hydroxydecanoate. Nevertheless, this difference was not statistically significant (n = 4; P . 0.05).
Effect of diazoxide and 5-hydroxydecanoate on tension in slow muscle fibers Previous reports have shown that diazoxide antagonizes fatigue by opening mitoK ATP channels, which was corroborated by adding 5-hydroxydecanoate and blocking the effect of diazoxide.
22 Figure 3 shows the results when diazoxide 30 µM and 5-hydroxydecanoate 500 µM were added. According to these results, there was an increase by 5.91% ± 4.99% with respect to control (standardized 100%). However, there was an increase of 26.0% ± 4.99% in peak tension, whereas the total tension increment was 44.87% ± 7.90% with respect to fatigue tension; nevertheless, the effect was statistically significant (P = 0.025 and P = 0.023, respectively). These results suggest that 5-hydroxydecanoate in combination with diazoxide acts as an agonist during fatigue, although it is possible that 5-hydroxydecanoate does not act as a selective inhibitor of mitoK ATP in the slow skeletal muscle fibers of the chicken, due to substrate conversion by β-oxidation.
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Effect of diazoxide and staurosporine on tension in slow muscle fibers Previous studies have implicated protein kinase C in mitoK ATP channel function. García et al 22 suggested that diazoxide has an antagonistic effect on muscle fatigue through several signaling routes. We studied the action of staurosporine (1 µM), a selective inhibitor for protein kinase C, in combination with diazoxide. Diazoxide and staurosporine caused an increase in post-fatigue tension in relation to muscle fatigue tension when added to the bath (Figure 4) . The maximum tension (control) dropped to 75.77% ± 2.47% in fatigued muscle. Nevertheless, there was an increase in peak tension of 120.75% ± 3.54% (postfatigue) and in total tension of 158.82% ± 8.60% . Both of these increases were statistically significant (P = 0.007 and P = 0.021, respectively). These results differ from those previously reported by García et al, 22 in which the effect of Effect of the combination of 5-hydroxydecanoate 500 µM and diazoxide 30 µM on the fatigued skeletal muscle tension, along with peak tension (P = 0.023) and total tension (P < 0.05). Note: *Represents statistical significance. There is a significant increase in postfatigue tension after application of both agents. First columns indicate controls standardized to 100%, second columns indicate a comparison of reduction of force from controls and third columns indicate the effect of used drugs compared against fatigue as 100%. diazoxide on post-fatigue tension was stronger when protein kinase C was blocked with chelerythrine and the two drugs were combined.
Effect of diazoxide and KT5823 on tension in slow muscle fibers
Previous reports have indicated that protein kinase G induces opening of the mitoK ATP channel in a manner similar to diazoxide. In addition, blockade of the channel by selective inhibition of protein kinase G with KT5823 has been reported. 19 To determine the possible participation of mitoK ATP during post-fatigue tension via this mechanism, KT5823 was used in combination with diazoxide. The combination of KT5823 1 µM with diazoxide resulted in an increase in post-fatigue tension with respect to the effect of diazoxide alone ( Figure 5 ). The increment in maximal tension was 16.17% ± 6.04%, whereas the increase in total tension was 63.88% ± 4.74%. Both of these increases in tension were statistically significant (P = 0.002 and P = 0.0001, respectively). Our results show that KT5823 did not antagonize the effect of diazoxide, therefore promoting an increase in post-fatigue tension.
Effect of diazoxide and L-NAME on postfatigue tension in slow muscle fibers
The effect of the combination of L-NAME, a selective nitric oxide synthase inhibitor, and diazoxide on mitoK ATP channels was investigated.
22 Figure 6 shows the effect of diazoxide 30 µM and L-NAME 100 µM on maximum and total tension. Comparing the average for muscle fatigue in relation to the control (100%), there was a decrease of 69.35% ± 5.18%, whereas the combination of diazoxide and L-NAME increased post-fatigue tension to 62.31% ± 12.38% (P = 0.0003) and produced a higher increase in total tension (91.22% ± 15.06% with respect to fatigue, P = 0.0004). García et al 22 reported inhibition when diazoxide plus L-NAME was present. However, our results showed just the opposite, ie, there was a remarkable increment in post-fatigue tension with a combination of the two drugs, and it was even higher with diazoxide alone.
Discussion
The ADP/ATP relationship is a reflection of the metabolic necessities of the cell. Therefore, a decrease in ATP has an important role in the development of muscle fatigue, and any event that alters the production of this metabolite can determine the tendency of the muscle to become fatigued. 30 In the present work, the effects of mitoK ATP channel agonists and antagonists were analyzed to clarify their possible participation during the fatigue process in slow skeletal muscle fibers of the chicken. Previously, García et al the participation of K ATP channels in avian muscle (anterior latissimus dorsi), 25 composed mainly of slow muscle fibers (type I). 31 It has been reported that diazoxide 100 µM increased post-fatigue tension, and it was proposed that mitoK ATP has a dominant role in this action. In the proposed analysis, diazoxide reduced fatigue without affecting twitches and/or tetanus, which suggests a direct influence on mitoK ATP , discarding any effect on sarcolemmal K ATP in addition to the specificity previously reported for this channel in isolated heart mitochondria. 13 It is important to point out that a diazoxide concentration was used and reported to have the maximum effects in these experiments. 28 In our results, diazoxide 30 µM had a statistically significant effect on post-fatigue tension (Figure 1) , consistent with the results of García et al 22 but at a lower dose. Activation of mitoK ATP channels reconstituted in liposomes or in rat skeletal muscle bundles is inhibited by 5-hydroxydecanoate. 13, 32 In contrast, we did not observe any effect on post-fatigue tension using 5-hydroxydecanoate 500 µM (data not shown). Perhaps this is because an intracellular mediator 13, 29 or an activator could be required in order to guarantee mitoK ATP activation. 22 Nevertheless, it is questionable to consider 5-hydroxydecanoate as a selective inhibitor because it is a potential metabolite for β-oxidation. 29 Recently, we have reported no modification in the respiratory rate of mitochondria from chicken skeletal muscle as a result of treatment with 5-hydroxydecanoate in relation to different respiratory substrates. 32 In this regard, Sarre et al 33 suggested the existence of other factors involved in the ischemic process implied during fatigue, upstream activation of protein kinase C, and inhibiting diazoxide activation of mitoK ATP with chelerythrine. Costa et al 18 and Costa and Garlid 19 suggested that protein kinase G induces the opening of mitoK ATP in a way similar to that achieved by the channel activators, diazoxide and cromakalim, in heart, liver, and brain mitochondria. Furthermore, they verified the suggested route through inhibition of channel opening by KT5823, a selective inhibitor of protein kinase G. García et al 22 proposed that protein kinase C and mitochondrial nitric oxide synthase act as intermediaries in the signaling route where mitoK ATP is involved. Another proposed factor for mitoK ATP activation is production of reactive oxygen species due to nitric oxide production and protein kinase C activation.
Our present results differ from those previously described for the heart and fast skeletal muscle of the rat. Nevertheless, it is important to mention that we worked with a different in vitro model of fatigue (avian slow skeletal muscle fibers) and with a different stimulation protocol (twitches). In our protocol, we successfully induced fatigue, and we considered that the fatigued muscle kept up its strength under ischemic conditions. 34, 35 Protein kinase C has been reported to have a central role during ischemic preconditioning. 18 According to previous studies, staurosporine inhibits the protective effect of ischemic preconditioning via protein kinase C inhibition in the rat heart. 36 Chelerythrine, a protein kinase C inhibitor, eliminates the inhibitory effect of diazoxide in fatigue. 22 In the present report, the combination of staurosporine with diazoxide showed an increase in post-fatigue tension (Figure 4) . Simultaneously, we used a selective inhibitor of protein kinase G (KT5823) to confirm whether protein kinase G takes part in the upstream mitochondrial signaling route of mitoK ATP through its phosphorylation. 18, 19 Thus, we observed an increase in post-fatigue tension. These results do not concur with those reported for the rat heart ( Figure 5 ). We suggest that KT5823 could not have effects on protein kinase G due to the experimental model (complete muscle) used. This is why it is necessary to perform experiments on single fibers and isolated mitochondria of skeletal muscle to confirm that KT5823 has an effect on protein kinase G in skeletal muscle.
In addition, the effects of the nitric oxide synthase inhibitor, L-NAME, were analyzed to determine whether mitoK ATP channels are involved in the effect of diazoxide on the signaling cascade that involves nitric oxide. Nitric oxide, an important messenger molecule in cells, is formed during skeletal muscle activity 37 and regulates mitoK ATP function. 28 L-NAME blocked the cardioprotective effects of diazoxide. 38 There is evidence indicating that nitric oxide directly activates mitoK ATP . 21, 39 García et al 22 maintain that a combination of diazoxide with L-NAME does not have any effect on postfatigue tension, which could indicate that L-NAME does indeed inhibit fatigue. In our case, we observed an increase in the presence of both drugs. It is possible that mitoK ATP could be activated by mitochondrial nitric oxide synthase, 33 a place the nitric oxide synthase inhibitor would not have access to.
In conclusion, the effects of K ATP channel inhibitors on muscle fatigue are controversial. In some studies, no significant effects on fatigue have been found, 40 ,41 while others have reported increases in fatigue. 42 Further studies are needed in order to understand better the pharmacological properties of this type of channel in this type of tissue, because they could be the key to identifying the cellular mechanisms involved in slow muscle fiber fatigue. fatigue composed of exclusively of slow muscle fibers, ie, the anterior latissimus dorsi of the chicken.
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